Swiss National Bank’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-166,700
| Closed | -$583K | – | 2454 |
|
|
2024
Q3 | $583K | Sell |
166,700
-12,400
| -7% | -$43.4K | ﹤0.01% | 2399 |
|
|
2024
Q2 | $587K | Buy |
+179,100
| New | +$587K | ﹤0.01% | 2382 |
|
|
2023
Q4 | – | Sell |
-171,000
| Closed | -$363K | – | 2566 |
|
|
2023
Q3 | $363K | Hold |
171,000
| – | – | ﹤0.01% | 2564 |
|
|
2023
Q2 | $814K | Buy |
171,000
+3,200
| +2% | +$15.2K | ﹤0.01% | 2397 |
|
|
2023
Q1 | $956K | Sell |
167,800
-19,600
| -10% | -$112K | ﹤0.01% | 2280 |
|
|
2022
Q4 | $1.89M | Buy |
187,400
+4,100
| +2% | +$41.4K | ﹤0.01% | 1931 |
|
|
2022
Q3 | $4.11M | Buy |
183,300
+1,600
| +0.9% | +$35.9K | ﹤0.01% | 1391 |
|
|
2022
Q2 | $4.5M | Buy |
181,700
+1,100
| +0.6% | +$27.3K | ﹤0.01% | 1376 |
|
|
2022
Q1 | $7M | Buy |
180,600
+13,100
| +8% | +$508K | ﹤0.01% | 1229 |
|
|
2021
Q4 | $9.8M | Buy |
167,500
+1,300
| +0.8% | +$76.1K | 0.01% | 1023 |
|
|
2021
Q3 | $9.85M | Buy |
166,200
+800
| +0.5% | +$47.4K | 0.01% | 1013 |
|
|
2021
Q2 | $14.4M | Buy |
165,400
+6,000
| +4% | +$521K | 0.01% | 832 |
|
|
2021
Q1 | $13.1M | Buy |
159,400
+2,300
| +1% | +$190K | 0.01% | 853 |
|
|
2020
Q4 | $14.3M | Buy |
157,100
+16,200
| +11% | +$1.47M | 0.01% | 763 |
|
|
2020
Q3 | $5.63M | Buy |
140,900
+6,000
| +4% | +$240K | ﹤0.01% | 1099 |
|
|
2020
Q2 | $4.63M | Buy |
134,900
+17,600
| +15% | +$604K | ﹤0.01% | 1191 |
|
|
2020
Q1 | $2.61M | Buy |
117,300
+4,000
| +4% | +$88.8K | ﹤0.01% | 1291 |
|
|
2019
Q4 | $2.22M | Buy |
113,300
+2,400
| +2% | +$47K | ﹤0.01% | 1669 |
|
|
2019
Q3 | $1.72M | Buy |
110,900
+14,800
| +15% | +$230K | ﹤0.01% | 1754 |
|
|
2019
Q2 | $1.95M | Buy |
96,100
+2,100
| +2% | +$42.6K | ﹤0.01% | 1707 |
|
|
2019
Q1 | $1.65M | Buy |
94,000
+5,300
| +6% | +$93.1K | ﹤0.01% | 1787 |
|
|
2018
Q4 | $1.14M | Buy |
88,700
+2,300
| +3% | +$29.5K | ﹤0.01% | 1927 |
|
|
2018
Q3 | $1.41M | Buy |
86,400
+12,900
| +18% | +$210K | ﹤0.01% | 1944 |
|
|
2018
Q2 | $833K | Buy |
+73,500
| New | +$833K | ﹤0.01% | 2269 |
|